Table I.
Point mutations
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
CLL case |
GenBank accession number |
VH gene | D gene | JH gene | Number of transcripts analyzed |
Total | Shareda | Partiallysharedb | Uniquec | Number of mutations expected by PCR error |
63 | AF021974 | 1-46 | D6-6 | JH6b | 29 | 0 | 0 | 0 | 0 | 0.29 |
67 | AF021990 | 4-34 | D2-15 | JH4b | 24 | 0 | 0 | 0 | 0 | 0.24 |
270 | AY055487 | 1-02 | D6-19 + D3-9 | JH4b | 28 | 1 | 0 | 0 | 1 | 0.28 |
141 | AF022005 | 4-34 | D2-2 | JH5b | 29 | 2 | 0 | 0 | 2 | 0.29 |
156 | AY055478 | 1-45 | D2-2 + D3-10 | JH5b | 27 | 2 | 0 | 0 | 2 | 0.27 |
7 | AY055477 | 3-49 | D3-3 | JH5a | 29 | 2 | 2 | 0 | 0 | 0.29 |
258 | AY05485 | 1-69 | D3-16 | JH3b | 30 | 3 | 0 | 0 | 3 | 0.30 |
216 | AY055483 | 3-49 | D5-12 | JH6b | 40 | 3 | 3 | 0 | 0 | 0.40 |
48 | AF0211969 | 1-02 | D6-13 | JH3b | 26 | 8 | 8 | 0 | 0 | 0.26 |
175 | AY055484 | 3 (HHG4) | D3-16 | JH6b | 28 | 9 | 2 | 0 | 7 | 0.28 |
249 | AY055479 | 3-23 | D2-21 | JH4b | 30 | 10 | 4 | 0 | 6 | 0.30 |
165 | AY055482 | 3-15 | D1-26 | JH6b | 30 | 14 | 14 | 0 | 0 | 0.30 |
178 | AY055482 | 2-05 | ND | JH4b | 30 | 17 | 13 | 0 | 4 | 0.30 |
136 | AF022002 | 4-34 | D2-2 | JH6b | 40 | 18 | 18 | 0 | 0 | 0.40 |
113 | AF021989 | 2-05 | ND | JH4b | 57 | 24 | 21 | 0 | 3 | 0.57 |
169 | AY055480 | 3-33 | D3-9 | JH4b | 50 | 26 | 24 | 0 | 2 | 0.50 |
261 | AY055486 | 3-33 | D5-12 | JH4b | 80 | 36 | 14 | 8 | 14 | 0.80 |
105 | AF021986 | 3-23 | D2-21 | JH4b | 60 | 40 | 5 | 11 | 24 | 0.60 |
Point-mutations in the Ig VHDJH gene transcripts of CLL B cells.
Shared, mutations shared by all the Ig VHDJH gene transcripts analyzed.
Partially shared, mutations shared but some but not all the Ig VHDJH gene transcripts analyzed.
Unique, mutations unique to distinct Ig VHDJH gene transcripts analyzed.
Based on error rate of 10−6 change/base/PCR cycle.